Last reviewed · How we verify

NCT07423624

Effect of 12 Weeks of Zumba Combined With Halotherapy on Body Composition, Respiratory, and Cardiorespiratory Parameters in Sedentary Older Adults

Completed NA Last updated 17 March 2026
What this trial tests

NA trial testing Zumba + Halotherapy Group in Zumba Exercise in 20 participants. Completed in 20 August 2024.

Timeline
5 May 2024
Primary endpoint
15 August 2024
20 August 2024

Quick facts

Lead sponsorGümüşhane Universıty
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment20
Start date5 May 2024
Primary completion15 August 2024
Estimated completion20 August 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gümüşhane Universıty

Who can join

Adults 55 to 80, any sex, with Zumba Exercise or Halotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial examined the effects of a 12-week Zumba exercise program combined with halotherapy on body composition, aerobic capacity, and physical fitness parameters in adult women. Participants were randomly assigned to a Zumba plus halotherapy group or a control group. Physical fitness tests and body composition measurements were performed before and after the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Gümüşhane Universıty trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07423624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing